Ten new medicines to treat a range of illnesses will be listed on the Pharmaceutical Benefits Scheme — and 121 will be cheaper.
From April 1, patients with Type 2 diabetes will benefit from expanded access to several newer diabetes medicines, known as gliptins, Berowra MP Philip Ruddock said.
He said prices will reduce for 121 drugs, including major price cuts to several cancer treatments and medicines for gastric reflux, depression and high cholesterol.
He said parents of children using Actemera for arthritis will appreciate the lower cost and cystic-fibrosis sufferers will welcome the addition to the PBS of Tobramycin in powder form for the treatment of bacterial lung infections.
Other medicines used to treat more rare forms of cancer, such as brain tumours and colorectal cancer, as well as for the treatment of scalp psoriasis and HIV, are also being added to the PBS.